Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP427772.RADzHI8mte4hsbR2EWbA2I03Yx-w6iOZwMjmgIyVWHdIo130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP427772.RADzHI8mte4hsbR2EWbA2I03Yx-w6iOZwMjmgIyVWHdIo130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP427772.RADzHI8mte4hsbR2EWbA2I03Yx-w6iOZwMjmgIyVWHdIo130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP427772.RADzHI8mte4hsbR2EWbA2I03Yx-w6iOZwMjmgIyVWHdIo130_provenance.
- NP427772.RADzHI8mte4hsbR2EWbA2I03Yx-w6iOZwMjmgIyVWHdIo130_assertion description "[There is evidence that UG, which is a potent inhibitor of the activity of phospholipases A2, has anti-proliferative effects and we have previously demonstrated that enforced UG expression reverts the transformed phenotype in the endometrial cancer cell line HEC-1A.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP427772.RADzHI8mte4hsbR2EWbA2I03Yx-w6iOZwMjmgIyVWHdIo130_provenance.
- NP427772.RADzHI8mte4hsbR2EWbA2I03Yx-w6iOZwMjmgIyVWHdIo130_assertion evidence source_evidence_literature NP427772.RADzHI8mte4hsbR2EWbA2I03Yx-w6iOZwMjmgIyVWHdIo130_provenance.
- NP427772.RADzHI8mte4hsbR2EWbA2I03Yx-w6iOZwMjmgIyVWHdIo130_assertion SIO_000772 14719079 NP427772.RADzHI8mte4hsbR2EWbA2I03Yx-w6iOZwMjmgIyVWHdIo130_provenance.
- NP427772.RADzHI8mte4hsbR2EWbA2I03Yx-w6iOZwMjmgIyVWHdIo130_assertion wasDerivedFrom befree-2016 NP427772.RADzHI8mte4hsbR2EWbA2I03Yx-w6iOZwMjmgIyVWHdIo130_provenance.
- NP427772.RADzHI8mte4hsbR2EWbA2I03Yx-w6iOZwMjmgIyVWHdIo130_assertion wasGeneratedBy ECO_0000203 NP427772.RADzHI8mte4hsbR2EWbA2I03Yx-w6iOZwMjmgIyVWHdIo130_provenance.
- befree-2016 importedOn "2016-02-19" NP427772.RADzHI8mte4hsbR2EWbA2I03Yx-w6iOZwMjmgIyVWHdIo130_provenance.